Factors associated with a willingness to accept latent tuberculosis infection treatment among non-U.S.-born individuals: a situational choice experiment
This study utilizes a situational choice experiment among non-U.S.-born adults in San Francisco to demonstrate that willingness to accept latent tuberculosis infection treatment is significantly driven by perceived progression risk, while being substantially reduced by concerns regarding side effects, out-of-pocket costs, and reinfection risks, thereby highlighting the need for shared decision-making that addresses these specific barriers.
Original paper dedicated to the public domain under CC0 1.0 (https://creativecommons.org/publicdomain/zero/1.0/). This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer
Tuberculosis is an ancient disease that still lingers in the shadows of modern life. While the active form of the illness makes people sick and spreads through the air, there is a silent, dormant version called latent tuberculosis infection. In this state, the bacteria sleep inside the body, causing no symptoms and posing no risk of spreading to others, yet they hold the potential to wake up and cause serious disease years later. For people living in the United States, especially those born in countries where the disease is common, this dormant infection is a widespread reality. The medical community has long known that a course of preventive treatment can put these sleeping bacteria to rest permanently, reducing the chance of future illness by a large margin. However, knowing that a cure exists is different from getting people to take it. Many individuals who are offered this preventive therapy simply do not start it, and the reasons why they hesitate are often hidden behind a wall of personal concerns, fears, and practical hurdles that doctors struggle to navigate.
To understand what truly drives these decisions, researchers at a community health center in the San Francisco Bay Area decided to ask the people themselves. They focused on adults born outside the United States who were receiving regular medical care, a group that carries a higher risk of having the dormant infection. Instead of just asking what people thought about the treatment in general, the team designed a unique survey that placed participants in a series of hypothetical situations. Imagine a game where a person is asked to choose between different versions of a medical plan, where each plan has a slightly different mix of benefits and drawbacks. In this study, the researchers created ten different scenarios for each person to consider. In every scenario, the risk of the infection waking up was described as low, medium, or high. Alongside that risk, the plans varied in their other details: some involved taking pills that might cause stomach upset or fatigue, while others warned of a small chance of liver trouble. Some plans required paying a fee out of pocket, while others were free. Some required a single trip to the clinic, while others demanded monthly visits or regular blood tests.
The participants were asked a simple question for each scenario: would you accept the treatment? If they said yes, they faced one more twist. They were told that even with the treatment, it is still possible to catch the infection again if they travel to a high-risk area in the future. They then had to decide if they would stick with their "yes" or change their mind and say no. By watching how people shifted their answers as the details changed, the researchers could see exactly which factors mattered most. The study found that the decision to accept treatment was not a simple yes or no based on a single rule, but a delicate balance of trade-offs. When the risk of the disease waking up was described as high, people were much more likely to say yes, regardless of other factors. The threat of the disease itself was the strongest driver of acceptance.
However, the study also revealed the specific barriers that could stop a person from saying yes, even when the risk was high. The most significant deal-breakers were the fear of liver injury and the cost of the treatment. When a scenario included a risk of liver inflammation, the willingness to accept the treatment dropped sharply. Similarly, when a fee of one hundred dollars was introduced, many people who might have accepted a free treatment suddenly declined. The researchers also found that the inconvenience of the treatment mattered. People were less willing to accept the plan if it meant stopping another medication they were already taking or if it required monthly blood draws. Interestingly, the fear of being reinfected in the future, while it did cause some people to change their minds, did not shake the decision as much as the immediate side effects or costs did.
The study suggests that there is no single way to convince everyone to take preventive treatment. What works for one person might not work for another. For some, the promise of avoiding a serious future illness is enough to overcome the fear of side effects. For others, the cost or the hassle of frequent clinic visits is simply too high a price to pay. The researchers noted that older adults, in particular, seemed more sensitive to the idea of having to change their current medications. The findings paint a clear picture of a population that is willing to engage with their health, but only when the terms of the deal make sense to them personally. The study does not claim to have solved the problem of low treatment uptake, but it provides a map of the obstacles. It shows that to improve the situation, doctors and public health officials need to move beyond a one-size-fits-all approach. Instead, they must listen to individual concerns, perhaps by offering treatment options with fewer side effects, removing financial barriers, or simply explaining the risks in a way that feels real and urgent to the person sitting in the exam room. By understanding these specific preferences, the path to better health becomes less about forcing a choice and more about finding the right key for each person's lock.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.